Ketamine-Assisted Therapy
Mind-Body & Movement

Ketamine-Assisted Therapy

Ketamine-Assisted Psychotherapy

Medically supervised ketamine treatment for treatment-resistant depression, PTSD, anxiety, and chronic pain. The only widely available legal psychedelic-assisted therapy. Produces rapid antidepressant effects within hours to days, compared to weeks for traditional medications.

100+ Studies80+ ReportsStrongIV + Intranasal (Spravato) + Sublingual
75
Kamura ScoreStrong
75/100
Strong
Strong
Evidence
1-3 sessions
Time to Effect
AED 1,500-4,000 per session
Est. Cost
Limited
UAE Access
Last reviewed: March 2025
80
Research
78
Community
60
Safety
55
Access
65
Value

How Ketamine-Assisted Therapy Works

Ketamine blocks NMDA glutamate receptors, triggering a rapid cascade of synaptic plasticity. This increases BDNF, activates mTOR, and stimulates synaptogenesis in the prefrontal cortex — essentially creating new neural connections that counteract depression-related brain atrophy.

📊 Evidence by Outcome

Depression ReliefA

Rapid antidepressant effect within 24-72 hours. 70% response rate in treatment-resistant depression. FDA-approved (Spravato/esketamine).

40 studies • Consistency: High • Effect: Large

Suicidal Ideation ReductionA

Uniquely rapid reduction in suicidal thoughts — within hours. Only approved treatment specifically for acute suicidal ideation.

15 studies • Consistency: High • Effect: Large

PTSD Symptom ReductionB

Significant PTSD symptom improvement when combined with psychotherapy. Effects may require maintenance sessions.

10 studies • Consistency: Moderate • Effect: Moderate

📄

Key Research

Peer-Reviewed Evidence • 1 Citations

[1]

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Zarate CA et al.Archives of General Psychiatry2006PMID: 16894061

Key Finding: Single IV ketamine infusion produced rapid antidepressant effects within 2 hours, with 71% response rate at 24 hours. Effects lasted up to 1 week.

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

Side Effects & Safety

Common(4)
DissociationNauseaDizzinessElevated blood pressure
Rare(2)
Cystitis with chronic useCognitive effects
Serious(2)
Addiction potentialPsychotic episodes (rare)

📋 Protocol Snapshot

IV Infusion Series
0.5mg/kg IV over 40 min, 6 sessions over 2-3 weeks
Standard induction protocol. Must be administered in clinical setting with monitoring.
Spravato (Intranasal)
56-84mg intranasal, 2x/week then weekly
FDA-approved esketamine. Must be administered in certified clinic with 2-hour observation.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Cost Guide

AED 1,500-4,000 per session

Limited UAE availability. Costs may vary for international sourcing.

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.